1. AstraZeneca gets FDA OK for Imfinzi in small-cell lung cancer— Regeneron and Sanofi treat first person outside US in coronavirus drug trial — FDA accepts Roche's NDA for Xofluza to treat flu in children — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

BMS ???

Discussion in 'Zymogenetics' started by Anonymous, Jun 8, 2011 at 11:56 AM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Ever since they bought us out things really have been ill-defined...BMS sucks!!
     

  2. Anonymous

    Anonymous Guest

    Why keep the corpse of Zymo? The people left are the dregs that caused their demise in the first place...
     
  3. Anonymous

    Anonymous Guest

    Start with getting rid of the asshole managers like CE, and it just might be a better place to work. Call reporting, Green Shits, too busy doing redundant lame as shit to know what a real sales is! Just glad I don't have him as a manager.
     
  4. Anonymous

    Anonymous Guest

    Welcome to BMS, bend over and grab your ankles, you're gonna get fucked.
     
  5. Anonymous

    Anonymous Guest

    Really? The recruiter told me $105k base, and $160 at plan. Is that not true? And how is the reimbursement for RECOTHROM these days? I have a good gig right now, but want into the OR space. Decent starting point?

    Thank you for real responses ahead of time.
     
  6. Anonymous

    Anonymous Guest

    105k base yes. More like 130k at plan. Not good if looking to "get in the OR". Things have never been worse with moral. Many are device reps who are miserable. What territory are you looking at?